Welcome to our dedicated page for Charlie S Holdin news (Ticker: CHUC), a resource for investors and traders seeking the latest updates and insights on Charlie S Holdin stock.
Charlie’s Holdings, Inc. (OTCQB: CHUC) is active in the premium vapor products space and regularly issues detailed updates on its operations, product lines, and regulatory strategy. This news page aggregates company announcements, including information on SBX non-nicotine products, PACHA synthetic nicotine and ENDS offerings, and the Pachamama 25K line produced through its U.S. manufacturing facility.
Recent news has highlighted strong SBX sales in multiple U.S. states, significant purchase orders from convenience store channels, and the opening of a domestic manufacturing facility in Huntington Beach, California, to meet new state-level requirements such as those in Texas. Charlie’s also reports on its PMTA portfolio, including income from PMTA asset sales and partnerships with strategic buyers, which the company views as an important component of its long-term business strategy.
Regulatory and compliance topics are a frequent focus of CHUC news releases. The company has announced a licensing agreement with IKE Tech LLC to integrate AI-powered, blockchain-based age-gating technology into SBX nicotine analogue products and PACHA-branded ENDS devices. News items describe how this system is intended to prevent underage users from activating devices and to address regulatory concerns related to flavored vapor products and youth access.
Investors and observers can also find updates on Charlie’s capital structure and corporate decisions, such as the discontinuation of hemp/CBD-related product sales through the Don Polly division, the use of a credit facility to support SBX inventory purchases, and participation in investor and industry conferences. This page provides a centralized view of these developments, allowing readers to follow how Charlie’s communicates its growth plans, regulatory posture, and operational changes over time.
Charlie's Holdings (OTCQB:CHUC) will exhibit at the NACS 2025 National Show in Chicago on Oct 15–17, 2025 (MAX Distributing Booth #N1440) and will present to investors at the LD Micro Main Event in San Diego on Oct 20, 2025 at 11:00am PST. The company will display its SBX and Pachamama 25K products and offer one-on-one investor meetings by request.
Management said Charlie's is profitable with minimal debt, plans to monetize PMTA-submitted PACHA synthetic nicotine products, and expects growing SBX distribution to support meeting uplist requirements to a national securities exchange. Contact and meeting requests: suzanne@chuc.com or LD Micro registration link.
Charlie's Holdings (OTCQB:CHUC) has secured a favorable $2 million credit facility from independent board member Michael D. King to support inventory purchases for their successful SBX™ product line. The facility includes three tranches ($1M initial, two $500K subsequent) at 13% interest rate with 12-month terms.
The non-dilutive financing comes as SBX sales exceed expectations in Southeast regions. In consumer testing, Charlie's non-nicotine SBX Disposables were preferred over Juul tobacco-flavored vapes by a 15:1 margin. The credit facility is notably shareholder-friendly, featuring no equity conversion rights or warrants, with King (who owns >2.5% of CHUC) indicating potential for additional funding if needed.
Charlie's Holdings (OTCQB:CHUC), a premium vapor products company, reported significant financial improvements in Q2 2025. The company achieved net income of $5.0 million ($0.02 EPS), compared to a $1.0 million loss in Q2 2024, marking its first profitable quarter since Q2 2023. Revenue increased 25% to $2.5 million, excluding $6.5 million from PMTA asset sales.
Key developments include successful SBX product launch in 6 states, strategic PMTA product partnerships generating $6.5 million in income with potential additional $4.2 million in contingent payments, and plans to open a US manufacturing facility in Q4 2025. The company reduced Notes Payable by $2.8 million in H1 2025 and maintains 679 remaining PMTAs valued at over $650 million.
Charlie's Holdings (OTCQB:CHUC), a premium vapor products company, has announced its Annual Shareholder Meeting for August 7, 2025, where it will discuss key strategic initiatives and uplisting plans. The company recently sold 15 PMTA products for $6.5 million with an additional contingent payment of up to $4.2 million to a major tobacco company.
Charlie's strategic focus includes monetizing its remaining 679 PMTA products, valued at over $300 million, launching nicotine-free SBX vapor products, developing age-gating technology, and introducing U.S.-filled products to comply with new state regulations. In consumer testing, 287 out of 306 participants preferred Charlie's SBX over Juul products. The company plans to uplist to Nasdaq or NYSE American once it meets listing requirements.
Charlie's Holdings (OTCQB:CHUC) announced the launch of PMTA registry-compliant 60ml e-liquid products under its PACHAMAMA brand in select states with FDA PMTA certification requirements. The launch includes five award-winning flavors, featuring "Fuji" and "Mint," targeting states like North Carolina, Kentucky, Oklahoma, Virginia, and Wisconsin that have implemented strict vapor product sales restrictions.
Charlie's is among a select few e-liquid manufacturers offering PMTA registry-compliant flavored e-liquids, with over 640 products under FDA regulatory review. The company has invested millions in PMTA submissions, positioning itself advantageously in a market where less than 1% of PMTAs for e-liquids and related products have survived FDA's regulatory process.
Charlie's Holdings (CHUC) announced FDA acceptance filings for eleven PACHA Disposables Pre-Market Tobacco Applications (PMTAs). Ten of these are for flavored PACHA Syn products, including varieties like Banana Ice, Blue Razz Ice, and Mango Ice. The company has invested over $7 million since 2020 on a team of 200+ professionals for PMTA submissions, with an additional $1 million investment in December 2024 to strengthen applications.
Notably, while pursuing PMTA approval, Charlie's is hedging with nicotine substitute products through their new SBX product line, which uses a proprietary alkaloid not subject to FDA tobacco regulations. The company acknowledges revenue reduction over the past two years due to resource redirection but sees SBX as a strategic opportunity in the vapor products marketplace.
Charlie's Holdings (OTCQB: CHUC) announced its participation in the LD Micro Main Event conference on October 29, 2024, in Santa Monica, California. The company revealed plans to launch SBX Disposables in November, featuring Metatine™ as a nicotine substitute. In a focus group survey, SBX was overwhelmingly preferred over Juul, with 287 out of 306 participants favoring Charlie's product.
The company has invested over $7MM in more than 700 Premarket Tobacco Application submissions with the FDA for various products. Charlie's COO Ryan Stump highlighted that SBX represents their largest commercial opportunity to date, offering a legal alternative across most of the United States.
Charlie's Holdings (OTCQB:CHUC) is set to launch SBX: America's Best Vape™, a revolutionary disposable device featuring patented Metatine™. SBX offers a legal alternative to flavored nicotine vapes across most of the United States. Key features include:
- 20ml capacity with 25,000 puffs
- Dual Mesh Coil for better taste
- Three power modes and customizable airflow
- Ten popular Charlie's flavors
SBX is not subject to regulatory restrictions that apply to most flavored vapes, as Metatine is not classified as a tobacco product. Charlie's believes this breakthrough will provide long-term competitive advantages in the vapor market. The product will be introduced at the National Association of Convenience Stores Convention in Las Vegas, October 8-10.
Charlie's Holdings (OTCQB: CHUC) reported its Q1 2024 financial results, showing a 24% revenue decrease to $3.1 million compared to Q1 2023. Despite this, gross profit increased by 6% to $0.9 million, and operating expenses decreased by 22% to $1.9 million. This led to a reduction in operating loss by 38% to $0.9 million, and net loss decreased by 25% to $1.0 million. Key initiatives include the development and launch of the SPREE BAR product line, using the new Metatine nicotine substitute. The company is focusing on increasing market awareness and preparing for further product launches in the second half of 2024.